Structure Therapeutics Inc. (GPCR) files initial Form 3 for CCO
Rhea-AI Filing Summary
Structure Therapeutics Inc. submitted a Form 3 for insider John Joseph Berrios, who serves as Chief Commercial Officer.
The report shows no buy, sell, or other equity transactions, no derivative transactions, and no holdings reported for him as of this initial statement.
Positive
- None.
Negative
- None.
Key Figures
Reported buy transactions: 0 transactions
Reported sell transactions: 0 transactions
Derivative transactions: 0 transactions
+1 more
4 metrics
Reported buy transactions
0 transactions
Buy transaction count in Form 3 transaction summary
Reported sell transactions
0 transactions
Sell transaction count in Form 3 transaction summary
Derivative transactions
0 transactions
Derivative transaction count in Form 3 transaction summary
Holding entries
0 holdings
Number of holdings reported for the insider in this Form 3
Key Terms
Form 3, Chief Commercial Officer, reporting person
3 terms
Form 3 regulatory
"INSIDER FILING DATA (Form 3):"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Chief Commercial Officer financial
"officer_title": "Chief Commercial Officer""
A chief commercial officer (CCO) is the senior executive responsible for a company’s revenue-generating activities, including sales, marketing, pricing, customer relationships and business development. Think of the CCO as the head coach who builds the game plan to win customers and grow sales; their effectiveness affects how fast a company earns money, enters new markets and sustains profits, making the role a key signal for investors about future revenue and competitive strength.
reporting person regulatory
""reportingPersons": [{ "name": "Berrios John Joseph""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 3 for Structure Therapeutics (GPCR) report about John Joseph Berrios?
It identifies John Joseph Berrios as Chief Commercial Officer of Structure Therapeutics Inc. and lists him as the reporting person, with no equity transactions, derivative transactions, or holdings reported in this initial Form 3.
Does the GPCR Form 3 show any stock purchases or sales by John Joseph Berrios?
No. The Form 3 transaction summary shows 0 buy transactions and 0 sell transactions, and the transactions list is empty, indicating no reported purchases or sales of Structure Therapeutics Inc. securities for this insider.
Are any derivative securities reported for John Joseph Berrios in Structure Therapeutics (GPCR) Form 3?
No derivative securities are reported. The derivative section is empty and the summary shows 0 derivative transactions, indicating no options, warrants, or other derivative positions are listed for him in this Form 3.
What insider role does John Joseph Berrios hold at Structure Therapeutics (GPCR)?
John Joseph Berrios is reported as an officer with the title Chief Commercial Officer. He is not marked as a director or a ten percent owner, making him an executive officer reporting person for Structure Therapeutics Inc.
Does the Structure Therapeutics (GPCR) Form 3 indicate any holdings for John Joseph Berrios?
No holdings are indicated. The structured data show 0 holding entries and an empty transactions list, so this initial Form 3 reports no beneficial ownership positions for John Joseph Berrios in the issuer’s securities.